Term
|
Definition
| Bronchodilator; Beta-2 Adrenergic Agonist |
|
|
Term
| ALBUTEROL: Common Concentration |
|
Definition
|
|
Term
| ALBUTEROL: Indications (1) |
|
Definition
|
|
Term
| ALBUTEROL: Contraindications (1) |
|
Definition
| Allergy/hypersensitivity to Albuterol |
|
|
Term
| ALBUTEROL: Precautions (3) |
|
Definition
1. Use of Beta Blockers (inhibits effect)
2. Caution with illnesses (heart dz, HTN, DM, elderly, antidepressant usage)
3. Potential or Positive TB patients: Nebulize only in well-ventilated area with EMS N95 usage |
|
|
Term
| ALBUTEROL: Side Effects (4) |
|
Definition
1. HTN and/or headache
2. Arrhythmias and/or chest pain
3. Nervousness and/or shakiness
4. Paradoxical bronchospasm (rare) |
|
|
Term
| ALBUTEROL: Adult Administration |
|
Definition
| Nebulizer, up to 3 total doses |
|
|
Term
| ALBUTEROL: Pediatric Administration |
|
Definition
| Nebulizer, up to 2 total doses |
|
|
Term
|
Definition
1. Analgesic
2. Platelet Anti-aggregate (slows blood-clotting mechanisms) |
|
|
Term
|
Definition
| 325mg tablet (or 81mg tablets x 4 tablets) |
|
|
Term
|
Definition
1. Suspected cardiac ischemia
2. Unstable angina |
|
|
Term
| ASPIRIN: Contraindications (2) |
|
Definition
1. Allergy to aspirin
2. Allergy to NSAIDs or Tylenol |
|
|
Term
|
Definition
1. Recent (3 months) internal bleeding
2. Bleeding disorder (GI bleed, ulcer disease, hemorrhagic stroke)
3. Recent surgery
4. Stroke patients
5. Possibility of pregnancy
6. Trauma patients
7. Asthma patients with current symptoms |
|
|
Term
| ASPIRIN: Side Effects (1) |
|
Definition
|
|
Term
| ALBUTEROL: Adult Administration |
|
Definition
|
|
Term
| ASPIRIN: Pediatric Administration |
|
Definition
<2yo: consult medical control
>2yo: 81mg PO x 1 dose |
|
|
Term
|
Definition
| Anticholinergic Bronchodilator |
|
|
Term
| IPRATROPIUM: Common Concentration |
|
Definition
|
|
Term
| IPRATROPIUM: Indications (1) |
|
Definition
| Bronchospasm (associated with chronic bronchitis, bronchial asthma, or emphysema) |
|
|
Term
| IPRATROPIUM: Contraindications (4) |
|
Definition
1. Allergy/hypersensitivity to drug
2. Allergy to soybeans or peanuts
3. Hypersensitivity to atropine
4. Acute treatment of bronchospasm where rapid response is required |
|
|
Term
| IPRATROPIUM: Precautions (2) |
|
Definition
1. Illness/disease (heart dz, HTN, glaucoma, elderly)
2. May worsen glaucoma if medication gets into eyes (have patient close eyes) |
|
|
Term
| IPRATROPIUM: Side Effects |
|
Definition
1. Common: cough, dry mouth, unpleasant taste
2. Rare: visual changes, eye burning, dizziness, headache, nausea, nervousness, sweating, dyspnea, chest tightness, rash, hives, facial swelling |
|
|
Term
| IPRATROPIUM: Adult Administration |
|
Definition
| Give only 1 dose. Only used in combination with albuterol. |
|
|
Term
| IPRATROPIUM: Pediatric Administration |
|
Definition
| Give only 1 dose. Only used in combination with albuterol. |
|
|
Term
|
Definition
| Hyperglycemic (increases circulation blood glucose levels) |
|
|
Term
| DEXTROSE 50%: Indications (1) |
|
Definition
| Suspected or known hypoglycemia (<80mg/dL) |
|
|
Term
| DEXTROSE 50%: Contraindications (1) |
|
Definition
| Intracranial hemorrhage from any cause |
|
|
Term
| DEXTROSE 50%: Precautions (2) |
|
Definition
1. Try to use larger bore IV in proximal vein. DO NOT ADMINISTER if any doubt of IV patency.
2. Should not be used as a diagnostic agent in Pt with altered LOC unless blood glucose is known to be <80mg/dL |
|
|
Term
| DEXTROSE 50%: Side Effects (3) |
|
Definition
1. May aggravate HTN and/or CHF
2. May cause tissue necrosis at injection site if infiltrates
3. May cause CNS symptoms in the alcoholic patient |
|
|
Term
| DEXTROSE 50%: Common Concentration |
|
Definition
|
|
Term
| DEXTROSE 50%: Adult Administration |
|
Definition
| Administer up to 25g slowly. Consider a second dose if no improvement and glucose still <80mg/dL. May be given orally to a conscious patient if blood glucose is >40mg/dL |
|
|
Term
| DEXTROSE 50%: Pediatric Administration |
|
Definition
1. <2yo: consult medical control
2. 2-12yo: (with blood glucose <60) Give D25 at a dose of 0.5-1g/kg. |
|
|
Term
| EPINEPHRINE 1:1000: Action (4) |
|
Definition
1. Stimulates alpha and beta receptors
2. broncodilator
3. Cardiac stimulator
4. Peripheral vasoconstrictor |
|
|
Term
| EPINEPHRINE 1:1000: Indications (4) |
|
Definition
1. Severe allergic reaction
2. Anaphylaxis
3. Severe asthma with no relief from albuterol
4. Cardiac arrest (as the concentration for ET route administration) |
|
|
Term
| EPINEPHRINE 1:1000: Precautions (1) |
|
Definition
| Caution in patients over 60 years old |
|
|
Term
| EPINEPHRINE 1:1000: Contraindications (1) |
|
Definition
| 1. NO IV ADMINISTRATION with this concentration (otherwise no absolute contraindications to epi in a life-threatening situation) |
|
|
Term
| EPINEPHRINE 1:1000: Side Effects (3) |
|
Definition
1. Nervousness/restlessness/tremors
2. Headache & HTN
3. Arrhythmias & Angina |
|
|
Term
| EPINEPHRINE 1:1000: Adult Administration |
|
Definition
Anaphylaxis: 0.3-0.4 mL SQ, up to 2 total doses.
Cardiac Arrest ET Tube Route: 2mg diluted with 8mL saline, repeat Q 5 minutes PRN |
|
|
Term
| EPINEPHRINE 1:1000: Pediatric Administration |
|
Definition
Anaphylaxis: 0.15mL SQ, total of 2 doses.
Cardiac Arrest ET route: 0.1mg/kg diluted with 3-5mL saline, Q5 minutes PRN |
|
|
Term
|
Definition
| Antihypoglycemic (converts liver glycogen to glucose) |
|
|
Term
| GLUCAGON: Indications (3) |
|
Definition
1. Hypoglycemia (<80mg/dL) if IV cannot be established
2. Beta Blocker OD/toxicity
3. Calcium Channel Blocker OD/toxicity |
|
|
Term
| GLUCAGON: Contraindications (1) |
|
Definition
| Allergy or hypersensitivity to drug |
|
|
Term
| GLUCAGON: Precautions (1) |
|
Definition
| May cause nausea and vomiting |
|
|
Term
| GLUCAGON: Common Concentration |
|
Definition
| 1mg/1mL after reconstitution of powder |
|
|
Term
| GLUCAGON: Adult Administration |
|
Definition
| Reconstitute. Give 1mg IM. |
|
|
Term
| GLUCAGON: Pediatric Administration |
|
Definition
If <2yo: consult medical control
If 2-12yo: Reconstitute. Give 1/2 mg IM. |
|
|
Term
|
Definition
|
|
Term
| ORAL GLUTOSE: Indications (1) |
|
Definition
|
|
Term
| ORAL GLUTOSE: Contraindications |
|
Definition
|
|
Term
| ORAL GLUTOSE: Precautions (2) |
|
Definition
1. Must have patent airway
2. Should not be used with altered LOC unless blood glucose is known to be <80 |
|
|
Term
| ORAL GLUTOSE: Adult Administration |
|
Definition
| Give 1 tube orally, monitor airway patency; up to 2 doses/tubes total |
|
|
Term
| ORAL GLUTOSE: Pediatric Administration |
|
Definition
| Give 7.5gm (1/2 tube) orally. Monitor airway patency; up to 2 total doses (15 grams total) |
|
|
Term
| ORAL GLUTOSE: Common Concentration |
|
Definition
|
|
Term
|
Definition
|
|
Term
| NALOXONE: Indications (2) |
|
Definition
1. Respiratory depression (<12/min) from narcotic overdose
2. As a diagnostic tool of coma of unknown origin |
|
|
Term
| NALOXONE: Contraindications |
|
Definition
| Allergy or hypersensitivity to drug |
|
|
Term
| NALOXONE: Precautions (3) |
|
Definition
1. Very short half-life, prepare to re-dose
2. Titrate to respiratory status, not level of consciousness
3. Consider patient restraints after narcotic reversal |
|
|
Term
| NALOXONE: Common Concentration |
|
Definition
|
|
Term
| NALOXONE: Adult Administration |
|
Definition
| Give 0.4-2mg IV titrated to respiratory status. Repeat every 2-3 minutes as needed up to 10mg total. |
|
|
Term
| NALOXONE: Pediatric Administration |
|
Definition
| Use Broselow Tape. Usually 0.1mg/kg if <20kg. |
|
|
Term
|
Definition
| Antianginal (coronary and peripheral vasodilator) |
|
|
Term
| SL NITROGLYCERIN: Indications (3) |
|
Definition
1. Chest pain of suspected cardiac origin
2. Pulmonary Edema
3. Hypertension |
|
|
Term
| SL NITROGLYCERIN: Contraindications (4) |
|
Definition
1. Allergy or known hypersensitivity to drug
2. Head trauma
3. Hypovolemia, hypotension (<90 systolic), or shock
4. Recent use (24-48hr) of erectile dysfunction drugs |
|
|
Term
| SL NITROGLYCERIN: Common Concentration |
|
Definition
| 0.4mg/tablet; 0.4mg/1 spray |
|
|
Term
| SL NITROGLYCERIN: Precautions (1) |
|
Definition
| May drastically decrease blood pressure |
|
|
Term
| SL NITROGLYCERIN: Side Effects (multiple) |
|
Definition
| Headache, dizziness, weakness, tachycardia, syncope, hypotension |
|
|
Term
| SL NITROGLYCERIN: Adult Administration |
|
Definition
Chest Pain: Give 0.4mg SL Q 5 minutes x 3 total doses.
HTN/Pulm Edema: give 0.4mg SL if symptomatic for a total of 2 doses |
|
|
Term
| SL NITROGLYCERIN: Pediatric Administration |
|
Definition
|
|
Term
| SL NITROGLYCERIN: Pediatric Administration |
|
Definition
|
|
Term
| SL NITROGLYCERIN: Pediatric Administration |
|
Definition
|
|
Term
| SL NITROGLYCERIN: Pediatric Administration |
|
Definition
|
|
Term
|
Definition
| Antiarrhythmic (slows conduction time through AV node). Half life of <10 seconds. |
|
|
Term
| ADENOSINE: Indicaions (1) |
|
Definition
| Conversion of PSVT to NSR (paroxysmal supraventricular tachycardia to Normal sinus rhythm) |
|
|
Term
| ADENOSINE: Contraindications (3) |
|
Definition
1. 2nd or 3rd degree heart block
2. Hypersensitivity
3. Poison/drug induced tachycardia |
|
|
Term
| ADENOSINE: Precautions (3) |
|
Definition
1. Heart transplant patients require a lower dose
2. Use caution in pregnancy
3. Wide complex tachycardia |
|
|
Term
| ADENOSINE: Common Concentration |
|
Definition
| 6mg and/or 12mg per vial/syringe |
|
|
Term
| ADENOSINE: Side Effects (5) |
|
Definition
1. Palpitations & Chest pain
2. Hypotension (rare with doses of 6-12mg)
3. Facial flushing & headahce
4. Brief periods of asystole, bradycardia, or ventricular ectopy
5. Dyspnea & bronchospasm |
|
|
Term
| ADENOSINE: Adult Administration |
|
Definition
6mg rapid IV push (followed immediately by 10-20mL NS flush). 2nd dose: 12mg. 3rd dose: 12mg.
(Heart transplant patients: 1st dose 4mg. 2nd dose 8mg.) |
|
|
Term
| ADENOSINE: Pediatric Administration |
|
Definition
| Contact medical control. Usually 0.1-0.2mg/kg initial dose. |
|
|
Term
|
Definition
| Topical anesthetic for eyes |
|
|
Term
| PROPARACAINE: Indications (3) |
|
Definition
1. Suspected corneal abrasion
2. Burns to the eye
3. Foreign body in eye |
|
|
Term
| PROPARACAINE: Contraindications (2) |
|
Definition
1. Hypersensitivity
2. Ruptured Globe |
|
|
Term
| PROPARACAINE: Precautions |
|
Definition
| Do not let patient rub/touch eyes |
|
|
Term
| PROPARACAINE: Adult Administration |
|
Definition
| Administer 1-2 drops in each affected eye. Repeat Q 15 minutes PRN. |
|
|
Term
| PROPARACAINE: Pediatric Administration |
|
Definition
| Administer 1 drop to each affected eye. Do not repeat without contacting medical control |
|
|
Term
|
Definition
| Class III antidysrhythmic. (delays cardiac repolarization rate, prolongs action potential for the heart, slows speed of electrical conduction, reduces SA node firing rate, slows conduction of accessory pathways, blocks potassium uptake) |
|
|
Term
| AMIODARONE: Indications (4) |
|
Definition
1. Ventricular Fibrillation
2. Ventricular Tachycardias (with and without pulse)
3. As prophylaxis following successful conversion of VF or VT
4. PSVT and WPW (with physician order) |
|
|
Term
| AMIODARONE: Contraindications (5) |
|
Definition
1. Allergy or hypersensitivity to drug
2. Pulmonary congestion or hypotension
3. Cardiogenic Shock
4. Sinus bradycardia
5. 2nd or 3rd degree AV block |
|
|
Term
| AMIODARONE: Precautions (7) |
|
Definition
1. May cause worsening of arrhythmia
2. May produce vasodilation and hyoptension
3. May have negative inotropic effecs
4. Extremely long half-life (60 days)
5. Caution in use with renal failure
6. May prolong QT interval
7. May interact with beta-blockers or some calcium-channel blockers and result in bradycardia |
|
|
Term
| AMIODARONE: Side Effects (5) |
|
Definition
1. Hypotension
2. Bradycardia
3. Headache/dizziness
4. Flushing
5. Cardiac Arrest |
|
|
Term
| AMIODARONE: Adult Administration |
|
Definition
1. Cardiac Arrest: 300mg IV bolus, followed by 150mg dose
2. VT with a pulse: 150mg IV over 2-3 minutes, repeat every 10 minutes PRN (max 2.2grams)
3. Non-sustained VT, Symptomatic PVCs: 150mg IV over 2-3 minutes |
|
|
Term
| AMIODARONE: Pediatric Administration |
|
Definition
| Cardiac arrest: 5mg/kg IV bolus. (or Broselow Tape). All other orders through medical control. |
|
|
Term
|
Definition
Benzodiazepine:
1. Anticonvulsant
2. Sedative |
|
|
Term
| LORAZEPAM: Indications (5) |
|
Definition
1. Prolonged/Recurrent seizures
2. Status epilepticus
3. Severe Anxiety or Combativeness
4. Relief of acute alcohol withdrawal
5. Relaxaion for elective cardioversion |
|
|
Term
| LORAZEPAM: Contraindications (3) |
|
Definition
1. Hypersensitivity
2. Shock, hypotension, CNS depression
3. Decreased LOC due to head injury |
|
|
Term
| LORAZEPAM: Precautions (2) |
|
Definition
1. May cause respiratory depression
2. May potentiate narcotics & barbituates |
|
|
Term
| LORAZEPAM: Side Effects (Multiple) |
|
Definition
| Respiratory depression, hypotension, sedation, confusion, nausea, vomiting, abdominal discomfort |
|
|
Term
| LORAZEPAM: Adult Administration |
|
Definition
1. Status Epilepticus: 2-4mg IV or 4mg IM (may reapeat Q 10 minutes up to 10 mg total)
2. Combative patients or severe anxiety: 2-4mg IV/IM (repeat Q 10 minutes PRN up to total 10mg) |
|
|
Term
| LORAZEPAM: Pediatric Administration |
|
Definition
| Status Epilepticus: Use Broselow Tape (usually 0.05-0.15mg/kg). Repeat 1 x only in 10 minutes. |
|
|
Term
|
Definition
Anticholinergic-Antimuscarinic (Parasympatholytic)
Antiarrhythmic; blocks parasympathetic response and allows sympathetic response to take over |
|
|
Term
| ATROPINE: Indications (5) |
|
Definition
1. Symptomatic bradyarrhythmias (<50/min); either supraventricular or ventricular
2. AV heart blocks with narrow complex
3. Cardiac Arrest (Bradycardic PEA or asystole)
4. In RSI (to treat bradycardia in pediatrics
5. Organophosphate Insecticide poisoning |
|
|
Term
| ATROPINE: Contraindications (2) |
|
Definition
1. Acute hemorrhage with unstable cardiovascular status
2. Tachycardia |
|
|
Term
| ATROPINE: Precautions (4) |
|
Definition
1. Should be given rapidly (to avoid paradoxical effect)
2. Avoid in hypothermic bradycardia
3. Asthma patients
4. 2nd and 3rd degree heart blocks are unresponsive to atropine (pace instead) |
|
|
Term
| ATROPINE: Side Effects (2) |
|
Definition
1. SVT, VT, or VF
2. Blurred vision, dry eyes, dilated pupils |
|
|
Term
| ATROPINE: Adult Administration |
|
Definition
1. Bradycardia: 0.5mg IV; repeat once if needed.
2. Asystole/PEA: 1mg IV; repeat Q 3-5 minutes PRN for a total of 3mg
3. Organophosphate poisoning: contact medical control |
|
|
Term
| ATROPINE: Pediatric Administration |
|
Definition
| Use Broselow Tape. (Usually 0.02mg/kg). For RSI in 0-7yo, 0.01mg/kg (minimum 0.1mg; Max 0.5mg) |
|
|
Term
|
Definition
| Antihistamine (H1 receptor antagonist; blocks histamine) |
|
|
Term
|
Definition
| Antihistamine (H1 receptor antagonist; blocks histamine) |
|
|
Term
|
Definition
| Antihistamine (H1 receptor antagonist; blocks histamine) |
|
|
Term
| DIPHENHYDRAMINE: Indications (2) |
|
Definition
1. Allergic Reactions (as adjunct to epi, or instead of epi if epi is contraidicated)
2. EPS (extrapyramidal symptoms: neck distortio, tongue rolling, parkinson-like tremors) from compazine administration |
|
|
Term
| DIPHENHYDRAMINE: Contraindications (3) |
|
Definition
1. Allergy or known hypersensitivity
2. Acute asthma attack
3. Newborns or premature infants |
|
|
Term
| DIPHENHYDRAMINE: Precautions |
|
Definition
| Has atropine-like action; use with caution in patients with bronchial asthma, hyperthyroidism, cardiovascular disease, HTN, an COPD |
|
|
Term
| DIPHENHYDRAMINE: Side Effects (multiple) |
|
Definition
| Drowsiness, sedation, dizziness, headache, blurred vision, palpitations, chest tightness, wheezing, thickening of bronchial secretions, hypotension, hallucinations, paradoxical excitement, convulsions |
|
|
Term
| DIPHENHYDRAMINE: Adult Administration |
|
Definition
1. Allergic Reactions: 25mg IV or 50mg IM
2. Conscious Sedation: 25-50mg IV/IM |
|
|
Term
| DIPHENHYDRAMINE: Pediatric Administration |
|
Definition
|
|
Term
|
Definition
| Electrolyte Modifier. Calcium is essential for transmission of nerve impulses in cardiac muscle contraction |
|
|
Term
| CALCIUM CHLORIDE: Indications (4) |
|
Definition
1. Symptomatic hyperkalemia
2. Hypocalcemia (esp from acute cases as hydrofluoric acid or fluorine gas exposure)
3. Respiratory depression following administration of MagSulfate
4. Calcium Channel Blocker overdose |
|
|
Term
| CALCIUM CHLORIDE: Contraindications |
|
Definition
| Not to be given in resuscitation unless hyperkalemia, hypocalcemia, or calcium channel blocker toxicity has been proven |
|
|
Term
| CALCIUM CHLORIDE: Precautions (3) |
|
Definition
1. Rapid administration may slow heart rate
2. In presence of Sodium Bicarb, will precipitate calcium salts or carbonates
3. Patients taking digitalis may have decreased ventricular irritability and Calcium may produce digitalis toxicity |
|
|
Term
| CALCIUM CHLORIDE: Side Effects (3) |
|
Definition
1. Arrhythmias, bradycardia, cardiac arrest
2. Tissue Necrosis at injection site
3. Syncope |
|
|
Term
| CALCIUM CHLORIDE: Adult Administration |
|
Definition
Consult Medical Control.
(Dose: 8-16mg/kg of 10% solution) |
|
|
Term
| CALCIUM CHLORIDE: Pediatric Administration |
|
Definition
Contact Medical Control.
(Dose: 0.2mL/kg or 20mg/kg slow IV) |
|
|
Term
|
Definition
| Narcotic, binds with opiate receptors in CNS (alters perception and emotional response to pain) |
|
|
Term
| HYDROMORPHONE: Indications (2) |
|
Definition
1. Musculoskeletal Trauma
2. Severe Pain |
|
|
Term
| HYDROMORPHONE: Contraindications (5) |
|
Definition
1. Pediatric patients
2. Patients in labor
3. Respiratory depression in asthmatics or COPD
4. Known allergies/hypersensitivities
5. Patients with increased intracranial pressure |
|
|
Term
| HYDROMORPHONE: Precautions (3) |
|
Definition
1. IV administration should be over 2-5 minutes
2. May be considered in patients with abdominal or head pain
3. Use with caution in patients with asthma or COPD presenting with respiratory difficulty |
|
|
Term
| HYDROMORPHONE: Side Effects (5) |
|
Definition
1. Dizziness/Sedation
2. Hypotension
3. Bradycardia
4. Nausea/vomiting
5. Respiratory Depression |
|
|
Term
| HYDROMORPHONE: Adult Administration |
|
Definition
| 0.5-2mg IV or IM, to a maximum dose of 2mg. CONSULT WITH MEDICAL CONTROL PRIOR TO GIVING TO A PATIENT WITH ABDOMINAL OR HEAD PAIN |
|
|
Term
| HYDROMORPHONE: Pediatric Administration |
|
Definition
| Not usually used in pediatrics. Contact medical control. |
|
|
Term
|
Definition
| Stimulates dopaaminergic, beta-1, and alpha receptors. Inotropic, vasopressor, increases blood pressure and cardiac output, and improves blood flow through kidneys |
|
|
Term
| DOPAMINE: Indications (2) |
|
Definition
1. Hypotension (<70-100 mmHg systolic) with signs and symptoms of shock
2. Secondary drug for symptomatic bradycardia |
|
|
Term
| DOPAMINE: Contraindications (1) |
|
Definition
|
|
Term
| DOPAMINE: Side Effects (5) |
|
Definition
1. Arrhythmias, chest pain, palpitations
2. Dyspnea
3. Hypotension (with abrupt withdrawal)
4. Dilated pupils
5. Tissue necrosis at IV site |
|
|
Term
| DOPAMINE: Common Concentration |
|
Definition
| 400mg in 250mL D5W (1600mcg/mL) |
|
|
Term
| DOPAMINE: Adult Administration |
|
Definition
|
|
Term
| DOPAMINE: Pediatric Administration |
|
Definition
| Do not use if <12yo without medical direction |
|
|
Term
| EPINEPHRINE 1:10,000: Action (4) |
|
Definition
1. Stimulates both alpha & beta receptors
2. Bronchodilator
3. Cardiac Stimulator
4. Peripheral Vasoconstrictor |
|
|
Term
| EPINEPHRINE 1:10,000: Indications (2) |
|
Definition
1. Cardiac Arrest
2. Severe anaphylaxis or asthma |
|
|
Term
| EPINEPHRINE 1:10,000: Contraindications |
|
Definition
| None in life-threatening emergencies |
|
|
Term
| EPINEPHRINE 1:10,000: Precautions (3) |
|
Definition
1. May precipitate with Sodium Bicarb
2. Rasing BP and heart rate may increase myocardial oxygen demand
3. Higher doses may be required to treat poison or drug-induced shock |
|
|
Term
| EPINEPHRINE 1:10,000: Side Effects (4) |
|
Definition
1. Arrhythmias and/or angina
2. Hypertension & headache
3. Nervousness/restlessness/tremors
4. May induce or exacerbate ventricular ectopy (especially in digitalis patients) |
|
|
Term
| EPINEPHRINE 1:10,000: Adult Administration |
|
Definition
1. Cardiac Arrest: 1mg IV Q 3-5min
2. Severe Anaphylaxis: 0.01mg/kg IV (up to 0.5mg)
3. Profound Bradycardia or hypotension: infuse 1-10mcg/min titrated to effect |
|
|
Term
| EPINEPHRINE 1:10,000: Pediatric Administration |
|
Definition
1. Cardiac Arrest: Use Broselow Tape (0.01mg/kg) IV Q 3-5 min
2. Symptomatic Bradycardia: 0.01mg/kg |
|
|
Term
|
Definition
1. General anesthesia
2. Sedative-hypnotic agent |
|
|
Term
| ETOMIDATE: Indications (2) |
|
Definition
1. Sedation for multiple trauma (without hypotension)
2. Sedation for head-injured patients |
|
|
Term
| ETOMIDATE: Contraindications (2) |
|
Definition
1. Known allergy to etomidate
2. Systolic <80mmHg |
|
|
Term
| ETOMIDATE: Precautions (3) |
|
Definition
1. Make sure all RSI medication and equipment are prepared prior to induction
2. May cause coughing or hiccups and may exacerbate focal seizures
3. No analgesic properties |
|
|
Term
| ETOMIDATE: Adult Administration |
|
Definition
| 0.3mg/kg IV for RSI, 0.2mg/kg prior to cardioversion |
|
|
Term
| ETOMIDATE: Pediatric Administration |
|
Definition
| 0.3mg/kg IV over 30-60 seconds |
|
|
Term
|
Definition
|
|
Term
|
Definition
1. Management of psychosis
2. Management of a combative patient |
|
|
Term
|
Definition
1. Suspected bone marrow depression
2. Respiratory disorders
3. Suspected hypotension |
|
|
Term
| HALDOL: Side Effects (multiple) |
|
Definition
| Dry mouth, nausea, vomiting, drowsiness, insomnia, headache, hypotension, bronchospasm, aspiration (suppresses cough reflex) |
|
|
Term
| HALDOL: Adult Administration |
|
Definition
|
|
Term
| HALDOL: Pediatric Administration |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
1. STEMI protocol
2. Anticoagulant therapy
3. Thrombosis |
|
|
Term
| HEPARIN: Contraindications (4) |
|
Definition
1. Active bleeding (except when due to DIC)
2. Severe hypertension
3. Bleeding disorders or known bleed (ex: GI bleed)
4. Known HIT (heparin induced thrombocytopenia) |
|
|
Term
| HEPARIN: Side Effects (4) |
|
Definition
1. Allergic reaction/anaphylaxis
2. Hemorrhage
3. Osteoporosis (long-term usage)
4. Thrombocytopenia |
|
|
Term
| HEPARIN: Adult Administration |
|
Definition
CONTACT MEDICAL CONTROL PRIOR TO ADMINISTRATION
STEMI: Loading dose of 60u/kg (max 4000u); follow with an infusion at 12u/kg/hr (max of 1000u/hr) |
|
|
Term
| HEPARIN: Pediatric Administration |
|
Definition
|
|
Term
|
Definition
| Ventricular antiarrhythmic |
|
|
Term
| LIDOCAINE: Indications (3) |
|
Definition
1. Alternative to amiodarone in VF/VT
2. Ventricular arrhythmias (symptomatic or significant PVCs)
3. Ventricular Tachycardia/Wide complex tachycardia with unknown/uncertain origin |
|
|
Term
| LIDOCAINE: Contraindications (4) |
|
Definition
1. Allergies to anesthetics
2. Prophylactic use in AMI is contraindicated
3. 2nd or 3rd degree heart block
4. Sinus Bradycardia with ventricular or nodal escape beats. (treat hypoxia first) |
|
|
Term
| LIDOCAINE: Precautions (3) |
|
Definition
1. Rapid administration in non-cardiac arrest can cause seizures
2. Treat monomorphic and polymorphic VT as the same
3. Reduce maintenance infusion by 50% if patient is over 70yo, has liver disease, is in CHF, or is in shock |
|
|
Term
| LIDOCAINE: Side Effects (5) |
|
Definition
1. Dizziness
2. Blurred or double vision
3. Respiratory depression or arrest
4. Excessive doses can produce hypotension
5. Nausea/vomiting |
|
|
Term
| LIDOCAINE: Adult Administration |
|
Definition
1. In cardiac arrest, 1-1.5mg/kg IV (max 3mg/kg); (for refractory VF, give additional 0.5-0.75mg/kg every 3-5 minutes)
2. Antiarrhythmic: initial bolus of 1.0-1.5mg/kg; second bolus of 0.5-0.75mg/kg if needed. An infusion of 2mg/min may be initiated as well. |
|
|
Term
| LIDOCAINE: Pediatric Administration |
|
Definition
| Use Broselow Tape. Cardiac Arrest: 1mg/kg IV (max of 100mg) |
|
|
